Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Braz J Microbiol ; 54(2): 1239-1249, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36877446

RESUMO

Crohn's disease (CD) is a chronic granulomatous inflammatory bowel disease with no fully understood etiology and cure. Mycobacterium avium subspecies paratuberculosis (MAP), the etiologic agent of paratuberculosis, is also isolated from samples from human patients with CD. Paratuberculosis is characterized by persistent diarrhea and progressive weight loss and primarily affects ruminants, which eliminate the agent via feces and milk. The involvement of MAP in the pathogenesis of CD and other intestinal diseases is unclear. Thus, the present study aimed to analyze immunological, socioepidemiological, biochemical, and therapeutic variables that may be related to the occurrence of MAP in blood samples and CD patients. The sampling was random, and the population of origin was the patients from the Bowel Outpatient Clinic of the Alpha Institute of Gastroenterology (IAG), Hospital das Clínicas, Universidade Federal de Minas Gerais (HC-UFMG). Blood samples were collected from 20 patients with CD, eight with ulcerative rectocolitis (UCR), and 10 control patients without inflammatory bowel diseases. Samples were subjected to real-time PCR for detection of MAP DNA, oxidative stress analyses, and socioepidemiological variables. MAP was detected in 10 (26.3%) of the patients, seven (70%) were CD patients, 2 (20%) were URC patients, and one (10%) was a non-IBD patient. MAP was found more frequently among CD patients, but not restricted to CD patients. The presence of MAP in the blood of these patients occurred simultaneously with an inflammatory response with an increase in neutrophils and significant alterations in the production of antioxidant enzymes such as catalase and GST.


Assuntos
Doença de Crohn , Doenças Inflamatórias Intestinais , Mycobacterium avium subsp. paratuberculosis , Paratuberculose , Animais , Humanos , Doença de Crohn/diagnóstico , Doença de Crohn/tratamento farmacológico , Doença de Crohn/microbiologia , Paratuberculose/microbiologia , Mycobacterium avium subsp. paratuberculosis/genética , Doenças Inflamatórias Intestinais/microbiologia , Intestinos
2.
Int J Parasitol ; 33(2): 153-62, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12633653

RESUMO

The initial steps of Leishmania infection in humans are largely unknown. There is limited information on the Leishmania infected human monocytes, the first cells that the parasite lives in, particularly related to costimulatory molecules. We show here that Leishmania (L.) chagasi infection avoids inducing proinflammatory molecules and has striking down modulating effects on human monocytes or macrophages. It does not induce CD54, interleukin (IL)-12 or tumour necrosis factor-alpha, potent proinflammatory cytokines and down modulates CD11b expression in monocytes. Lipopolysaccharide stimulated IL-12 (p40) levels, CD54 and HLA-DR expression are diminished in infected monocytes as well as interferon-gamma stimulated HLA-DR and HLA-ABC expression in infected macrophages. There is a negative correlation between CD54 and CD86 expression in both monocytes and macrophages. The depressed expression of class I and II molecules, absence of key proinflammatory cytokines and impaired expression of costimulatory molecules induced by L. chagasi could leave the immune system, at least in its initial phases in anergy or ignorance.


Assuntos
Antígeno B7-1/metabolismo , Leishmania infantum/patogenicidade , Leishmaniose Visceral/imunologia , Leishmaniose Visceral/parasitologia , Macrófagos/parasitologia , Monócitos/parasitologia , Animais , Antígenos CD/imunologia , Antígeno B7-2 , Antígeno CD11b/imunologia , Adesão Celular , Células Cultivadas , Citocinas/imunologia , Regulação para Baixo , Citometria de Fluxo , Antígenos HLA/imunologia , Humanos , Molécula 1 de Adesão Intercelular/imunologia , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Ativação Linfocitária , Macrófagos/imunologia , Glicoproteínas de Membrana/imunologia , Monócitos/imunologia
3.
Infect Immun ; 69(12): 7453-60, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11705920

RESUMO

The initial encounter of Leishmania cells and cells from the immune system is fundamentally important in the outcome of infection and determines disease development or resistance. We evaluated the anti-Leishmania amazonensis response of naive volunteers by using an in vitro priming (IVP) system and comparing the responses following in vivo vaccination against the same parasite. In vitro stimulation allowed us to distinguish two groups of individuals, those who produced small amounts of gamma interferon (IFN-gamma) (n = 16) (low producers) and those who produced large amounts of this cytokine (n = 16) (high producers). IFN-gamma production was proportional to tumor necrosis factor alpha and interleukin 10 (IL-10) levels but did not correlate with IL-5 production. Volunteers who produced small amounts of IFN-gamma in vitro remained low producers 40 days after vaccination, whereas high producers exhibited increased IFN-gamma production. However, 6 months after vaccination, all individuals tested produced similarly high levels of IFN-gamma upon stimulation of their peripheral blood mononuclear cells with Leishmania promastigotes, indicating that low in vitro producers respond slowly in vivo to vaccination. In high IFN-gamma producers there was an increased frequency of activated CD8(+) T cells both in vitro and in vivo compared to the frequency in low producers, and such cells were positive for IFN-gamma as determined by intracellular staining. Such findings suggest that IVP responses can be used to predict the pace of postvaccination responses of test volunteers. Although all vaccinated individuals eventually have a potent anti-Leishmania cell-mediated immunity (CMI) response, a delay in mounting the CMI response may influence resistance against leishmaniasis.


Assuntos
Interferon gama/biossíntese , Leishmaniose/imunologia , Vacinas Protozoárias/imunologia , Adolescente , Adulto , Linfócitos T CD8-Positivos/imunologia , Previsões , Humanos , Imunidade Inata , Ativação Linfocitária , Masculino , Receptores de Interleucina-2/isolamento & purificação , Subpopulações de Linfócitos T/imunologia , Vacinação
4.
Braz J Med Biol Res ; 34(10): 1309-13, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11593306

RESUMO

Sickle cell disease has a worldwide distribution and is a public health problem in Brazil. Although vaso-occlusive crisis (VOC) is one of the most important clinical features of the disease, there are still several steps of its pathogenesis which are unknown. The increase of the chemotactic factor interleukin 8 (IL-8) has been reported to be involved in sickle cell disease crisis, but this has not been demonstrated conclusively. In the present study we analyzed serum IL-8 levels by ELISA and hematological parameters and hemoglobin patterns by standard techniques in 23 (21 SS and 2 SC) Brazilian patients with sickle cell syndromes during VOC caused by different inducing factors, 22 (21 SS and 1 SC) sickle cell patients out of crisis, and 11 healthy controls. Increased IL-8 levels were observed in 19 of 23 VOC patients (79.2%), 3 of them with more than 1,000 pg/ml. Seventeen of 22 (77.3%) non-crisis patients showed low IL-8 levels (less than 15 pg/ml). Healthy controls had low IL-8 levels. A significant difference in serum IL-8 levels was observed between crisis and non-crisis sickle cell patients (P<0.0001). There was no correlation between IL-8 levels and hematological data or hemoglobin patterns. High serum IL-8 levels were observed in VOC patients independently of the crisis-inducing factor. We conclude that in the studied population, IL-8 concentration may be a useful VOC marker, although the mechanism of the pathogenic process of sickle cell VOC syndromes remains unclear.


Assuntos
Anemia Falciforme/sangue , Arteriopatias Oclusivas/sangue , Interleucina-8/sangue , Adolescente , Adulto , Anemia Falciforme/fisiopatologia , Arteriopatias Oclusivas/etiologia , Biomarcadores/sangue , Brasil , Criança , Pré-Escolar , Feminino , Hemoglobina Falciforme/análise , Hemoglobinas/análise , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Síndrome
5.
Braz. j. med. biol. res ; 34(10): 1309-1313, Oct. 2001. tab, graf
Artigo em Inglês | LILACS | ID: lil-299851

RESUMO

Sickle cell disease has a worldwide distribution and is a public health problem in Brazil. Although vaso-occlusive crisis (VOC) is one of the most important clinical features of the disease, there are still several steps of its pathogenesis which are unknown. The increase of the chemotactic factor interleukin 8 (IL-8) has been reported to be involved in sickle cell disease crisis, but this has not been demonstrated conclusively. In the present study we analyzed serum IL-8 levels by ELISA and hematological parameters and hemoglobin patterns by standard techniques in 23 (21 SS and 2 SC) Brazilian patients with sickle cell syndromes during VOC caused by different inducing factors, 22 (21 SS and 1 SC) sickle cell patients out of crisis, and 11 healthy controls. Increased IL-8 levels were observed in 19 of 23 VOC patients (79.2 percent), 3 of them with more than 1,000 pg/ml. Seventeen of 22 (77.3 percent) non-crisis patients showed low IL-8 levels (less than 15 pg/ml). Healthy controls had low IL-8 levels. A significant difference in serum IL-8 levels was observed between crisis and non-crisis sickle cell patients (P<0.0001). There was no correlation between IL-8 levels and hematological data or hemoglobin patterns. High serum IL-8 levels were observed in VOC patients independently of the crisis-inducing factor. We conclude that in the studied population, IL-8 concentration may be a useful VOC marker, although the mechanism of the pathogenic process of sickle cell VOC syndromes remains unclear


Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Anemia Falciforme , Arteriopatias Oclusivas , Interleucina-8 , Anemia Falciforme , Arteriopatias Oclusivas , Biomarcadores , Brasil , Hemoglobina Falciforme , Hemoglobinas , Fatores de Risco , Síndrome
6.
Neurosci Lett ; 181(1-2): 1-4, 1994 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-7534888

RESUMO

The nitric oxide synthase (NOS) present in the cytosol obtained from rat cerebral cortex synaptosomes was inhibited by NG-nitro-L-arginine (L-NOArg) with an IC50 value of approximately 0.06 microM. This compound did not affect the transport of L-arginine (L-Arg) into synaptosomes at concentrations up to 100 microM but other potential inhibitors of NOS (NG-monomethyl-L-arginine, NG-amino-L-arginine and L-arginine methyl ester) inhibited L-Arg transport at a concentration < 5 microM. We showed that concentrations of L-NOArg (0.001-3 microM) that did not block the uptake of tritiated arginine (L-[3H]Arg) inhibited the catalytic activity of NOS in intact synaptosomes. L-NOArg at a concentration of 1 microM inhibited the cytosolic enzyme by 98.0 +/- 2.0% of the total NOS activity whereas the enzyme studied in the intact synaptosomes was only inhibited by 75 +/- 5% which suggested that the NOS in synaptosomes is not fully accessible to the external L-NOArg. On the other hand, L-Lysine did not inhibit the cytosolic NOS activity of ruptured synaptosomes but at a concentration that blocked 50.0 +/- 4.5% of L-[3H]Arg uptake it inhibited the NOS activity in intact synaptosomes by 12.6 +/- 3.6%, suggesting that the transport of L-Arg may be an important regulatory step in the pathway for nitric oxide generation.


Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Aminoácidos/farmacologia , Arginina/antagonistas & inibidores , Encéfalo/metabolismo , Sinaptossomos/metabolismo , Animais , Arginina/análogos & derivados , Arginina/metabolismo , Arginina/farmacologia , Transporte Biológico/efeitos dos fármacos , Embrião de Galinha , Citosol/metabolismo , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico Sintase , Nitroarginina , Ratos , Ratos Wistar , Trítio , ômega-N-Metilarginina
7.
Acta Trop ; 44(1): 5-11, 1987 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2884839

RESUMO

We have infected BALB/c and C57BL/6 mice with a cloned Leishmania mexicana amazonensis population, obtained from the "Maria" strain. Progression of infection and histopathological examination confirmed the extreme susceptibility of BALB/c mice and the resistant pattern of the C57 BL/6. Anti-Leishmania antibody titers were higher in BALB/c than in C57BL/6 mice through the period of infection. Tests of delayed type hypersensitivity reaction with Leishmania antigens were positive in both strains in the beginning of the infection, but were negative later on in BALB/c mice. Our results are similar to those obtained with mixed parasite populations, and rule out the possibility of selection among different parasite subpopulations as responsible for the divergent course of the disease exhibited by these two strains of mice.


Assuntos
Leishmaniose/fisiopatologia , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Animais , Anticorpos/análise , Feminino , Hipersensibilidade Tardia/imunologia , Leishmania mexicana/imunologia , Leishmaniose/imunologia , Leishmaniose/patologia , Camundongos
8.
Mem Inst Oswaldo Cruz ; 82 Suppl 4: 269-71, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3151102

RESUMO

Immunological tolerance to Schistosoma mansoni antigens induced by oral exposure of neonatal and adult mice to adult worm, soluble egg and polysaccharide antigens conducted to modulated periovular granuloma of infected mice. However the tolerance do not interfere in the infection. The estimative population and subpopulation of lymphocytes in the spleen of tolerized (not infected) animals do not differ from normal animals but Lyt 2.2 reactive lymphocytes to Schistosoma antigens was demonstrated in the tolerized animals.


Assuntos
Antígenos de Helmintos/imunologia , Granuloma/patologia , Schistosoma mansoni/imunologia , Esquistossomose mansoni/patologia , Administração Oral , Animais , Anticorpos Anti-Helmínticos/biossíntese , Antígenos de Helmintos/administração & dosagem , Tolerância Imunológica , Imunização , Fígado/patologia , Camundongos , Esquistossomose mansoni/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA